Stefan Cardinal Wyszyński National Institute of Cardiology

The Stefan Cardinal Wyszyński National Institute of Cardiology serves as the central command and primary clinical epicenter of cardiovascular medicine in Poland. Founded in 1979, this prestigious state-directed National Research Institute completely transcends the profile of a standard civic hospital, operating instead as a premier European brain trust holding the elusive national A+ research category ranking. As a result, 40% of all transplants in Poland are performed here, with a high survival rate compared to the average at other centers. The clinic meets the high-quality criteria of ISO 9001:2000. More than 16,000 patients receive services in inpatient departments, and 63,000 consult outpatients. About 2,100 operations per year are sufficient to maintain the necessary experience and proper development of the cardiac surgical field. In addition, the hospital became the first to use telemedicine to consult patients worldwide. This approach is especially relevant for foreign patients who can maintain contact with the doctor after discharge. The tranquil, wooded microclimate surrounding the campus provides an intentional, low-stimulus physiological anchor for patients, creating a striking contrast to the high-velocity, intellectually intense clinical engineering taking place within its walls, where the entire nation's most complex hemodynamic and electrophysiological failures are caught, analyzed, and reversed. The institute is uniquely built around the total, uncompromised orchestration of advanced cardiac surgery, complex electrophysiology, and mechanical circulatory support. As Poland’s premier reference center, the facility manages an extraordinary annual workflow, pioneering the deployment of transcatheter aortic valve implantations (TAVI), high-density 3D mapping for complex arrhythmia ablations, and the surgical management of advanced adult congenital heart defects. Its specialized intensive care blocks and cardiac theaters function as an aggressive engineering laboratory where failing myocardial systems are stabilized using state-of-the-art ventricular assist devices and extracorporeal life support, bridging critically ill patients to definitive heart transplantation. This technical precision is profoundly balanced by the institute’s foundational, deeply internalized clinical philosophy, captured by its iconic institutional motto: “It is not enough to approach a patient with expertise, experience, care, and conscientiousness. You must show them, heart!” The medical center has high-tech equipment for quick, precise diagnosis of disorders, including 384-multislice CT, MRI, nuclear medicine imaging, SPECT-CT, Echo, and ultrasound diagnostic devices. The availability of arrhythmia and hemodynamic monitoring, artificial respiration devices, and bedside renal replacement therapy enables the facility to provide emergency and intensive care in the most challenging cases. The additional use of therapeutic hypothermia and mechanical cardiac support is a significant measure to save a patient's life during cardiac arrest and significantly reduces the risk of complications. A significant achievement of the medical center was the use of robotics in electrophysiology with the Genesis magnetic navigation robotic system from Stereotaxis. Thanks to modern technologies, the clinic provides gentle, organ-preserving treatment for arrhythmias, with no analogs in the country. Patients also have access to unique treatments owing to numerous clinical studies conducted at the medical center, including studies of genetic mutations in cardiomyopathies, use of 64-slice CT scans for non-invasive coronary angiography, treatment of valvular disease with non-stent valves and homografts, and many others. Stefan Cardinal Wyszyński National Institute of Cardiology provides cardiological, vascular, and coronary heart disease treatment; congenital and valvular defect treatment; cardiomyopathy treatment; arrhythmia control; heart transplantation; and rehabilitation. The development of molecular biology technologies in diagnostics and minimally invasive treatment methods allows the clinic's doctors to achieve positive treatment outcomes. In addition, the low risk of complications, high survival rates, and remote patient support at home make the medical center the institution of choice for treatment. This humanistic guiding principle is seamlessly integrated into the highly active clinical research support center, which organizes dozens of pioneering commercial and non-commercial clinical trials in partnership with international networks such as the European Clinical Research Infrastructure Network (ECRIN). What firmly isolates this Warsaw titan as an irreplaceable monument of public health is its macro-level mandate to monitor, evaluate, and shape the epidemiological landscape of cardiovascular survival across the entire Polish state. Rather than focusing solely on individual bedside outcomes, the institute operates a vast national epidemiological matrix that tracks cardiovascular morbidity and hospital mortality nationwide, translating massive datasets into active public health policies and modern post-graduate medical education. In its specialized molecular biology and genomics laboratories, scientists investigate the microscopic underpinnings of arterial hypertension, cardiomyopathy, and rare inherited cardiovascular syndromes, constantly bridging the gap between genetic code and clinical pharmacology.